ARTICLE | Clinical News
Motorgraft regulatory update
December 21, 2009 8:00 AM UTC
FDA granted Orphan Drug designation for California Stem Cell's Motorgraft to treat spinal muscular atrophy (SMA). The company plans to submit an IND for the stem cell-derived motor neuron replacement ...